Stimulating pharmaceutical innovation in the EU
- Author
- Lieven Annemans (UGent), Irina Cleemput, Frank Hulstaert and Steven Simoens
- Organization
- Keywords
- clinical trials, medical needs, intellectual property rights, orphan medicines, pharmaceutical innovation
Downloads
-
- full text
- |
- UGent only
- |
- |
- 797.61 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-2014491
- Chicago
- Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2011. “Stimulating Pharmaceutical Innovation in the EU.” Expert Review of Pharmacoeconomics & Outcomes Research.
- APA
- Annemans, Lieven, Cleemput, I., Hulstaert, F., & Simoens, S. (2011). Stimulating pharmaceutical innovation in the EU. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.
- Vancouver
- 1.Annemans L, Cleemput I, Hulstaert F, Simoens S. Stimulating pharmaceutical innovation in the EU. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2011. p. 235–9.
- MLA
- Annemans, Lieven, Irina Cleemput, Frank Hulstaert, et al. “Stimulating Pharmaceutical Innovation in the EU.” EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 2011 : 235–239. Print.
@misc{2014491,
author = {Annemans, Lieven and Cleemput, Irina and Hulstaert, Frank and Simoens, Steven},
issn = {1473-7167},
keyword = {clinical trials,medical needs,intellectual property rights,orphan medicines,pharmaceutical innovation},
language = {eng},
number = {3},
pages = {235--239},
series = {EXPERT REVIEW OF PHARMACOECONOMICS \& OUTCOMES RESEARCH},
title = {Stimulating pharmaceutical innovation in the EU},
url = {http://dx.doi.org/10.1586/ERP.11.19},
volume = {11},
year = {2011},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: